title: Brånemark Novum: a new treatment concept for rehabilitation of the edentulous mandible. Preliminary results from a prospective clinical follow-up study.
abstract: BACKGROUND
  Brånemark fixtures were originally prescribed to be placed in two surgical stages. During the past years, reports on the placement of machined titanium implants in a one-stage procedure have been published, and the results have been encouraging. Recently there has been considerable interest in early or immediate loading.
  
  
  OBJECTIVE
  The purpose of this article is to report the preliminary clinical results of a new method for implant treatment of the edentulous mandible. The new protocol involves prefabricated components and surgical guides, elimination of the prosthetic impression procedure and attachment of the permanent fixed bridge on the day of implant placement.
  
  
  METHODS
  Fifty patients (26 males, 24 females) received 150 Brånemark Novum implants and were followed from 6 months to 3 years after implant placement. Bone width and height were determined preoperatively with the use of radiographs. The jaw was reduced in height to accommodate three special 5-mm wide implants. Precise implant positioning was accomplished with special drilling templates. Drill guides were placed over the drilling templates during site preparation using a series of specially designed drills. After the mucosa had been sutured back into position, a prefabricated titanium lower bar was connected with titanium screws to the transmucosal fixture. Another titanium bar was then attached by the prosthodontist, and a bite registration was performed. The bridge was attached to the upper bar. The permanent reconstruction was provided to the patient later the same day.
  
  
  RESULTS
  Three implants were lost to follow-up and three failed, resulting in an overall survival rate of 98%. One prosthesis failed, leaving a prosthetic survival rate of 98%. The average treatment time was approximately 7 hours. At the baseline examination, the marginal bone level was 0.72 mm below the reference point. The average marginal bone loss was 0.2 mm per year and 0.26 mm between the 3-month and 1-year control visits. The accumulated mean bone loss, including baseline, was -1.25 mm. A patient questionnaire demonstrated that 94% of the patients did not experience any discomfort during treatment and all patients would recommend the procedure to others.
  
  
  CONCLUSIONS
  The results of this study indicate that the precise surgical and prosthetic protocol allows successful prosthetic rehabilitation of mandibular edentulism and that the permanent reconstruction can be provided to the patient on the day of fixture surgery.
authors.affiliation: Brånemark Osseointegration Center, Box 5411, SE-402 29 Göteborg, Sweden.
authors.forename: P I
authors.initials: PI
authors.lastname: Brånemark
authors.forename: P
authors.initials: P
authors.lastname: Engstrand
authors.forename: L O
authors.initials: LO
authors.lastname: Ohrnell
authors.forename: K
authors.initials: K
authors.lastname: Gröndahl
authors.forename: P
authors.initials: P
authors.lastname: Nilsson
authors.forename: K
authors.initials: K
authors.lastname: Hagberg
authors.forename: C
authors.initials: C
authors.lastname: Darle
authors.forename: U
authors.initials: U
authors.lastname: Lekholm
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003758:Dental Implantation, Endosseous / Q000379:methods*; D003761:Dental Impression Technique; D017267:Dental Prosthesis Design; D017268:Dental Prosthesis Retention; D019094:Dental Prosthesis, Implant-Supported; D019232:Dental Restoration Failure; D003825:Denture, Complete, Immediate; D017050:Episode of Care; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007575:Jaw, Edentulous / Q000000981:diagnostic imaging / Q000534:rehabilitation* / Q000601:surgery; D008297:Male; D008334:Mandible / Q000601:surgery; D008875:Middle Aged; D008953:Models, Anatomic; D010347:Patient Care Planning; D017060:Patient Satisfaction; D011446:Prospective Studies; D011859:Radiography; D011795:Surveys and Questionnaires; D016896:Treatment Outcome